Advertisement

Topics

Forest Laboratories, Inc. and Almirall, S.A. Company Profile

10:39 EDT 22nd June 2018 | BioPortfolio

Forest Laboratories' (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well-established central nervous system and cardiovascular franchises and innovations in anti-infective, respiratory, gastrointestinal and pain management medicine. Forest’s pipeline, the most robust in its history, includes product candidates in all stages of development across a wide range of therapeutic areas. The Company is headquartered in New York, NY. To learn more, visit www.FRX.com.


News Articles [413 Associated News Articles listed on BioPortfolio]

Forest Blow, PTV News: Apr 08, 2010

FDA panel says no to Forest Laboratories' lung drug Daxas

Almirall up 4% as 1st-qtr results hint at better times

Shares in Almirall closed 4% up on Monday at 10.60 euros after Spain’s biggest drugmaker revealed its…

Almirall: Jordi Sabe. An International Speciality Pharma Company Focused on Respiratory, Dermatology , Gastroenterology and Pain

In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Jordi Sabe, Director, Corporate Development - Licensing & M&A at Almirall

Hiding from a warmer climate in the forest

(Stockholm University) Global warming threatens forest plants adapted to cooler temperatures. An international team of scientists from the universities of Stockholm, Marseille and Helsinki have unrave...

Interview: Almirall CEO Guenter Plots 'Play To Win' Future

Peter Guenter has steadied the ship at Almirall, and after seven months in the role he outlines his vision for...    

Guenter Stays Focused After Almirall's Annus Horribilis

Peter Guenter, brought in from Sanofi to fix the problems at Almirall, is staying focused on 2018 as he outlines...   

Forest City Seats New Independent Directors

"We are thrilled to welcome our new independent directors to the Forest CityBoard," said David LaRue, President and Chief Executive Officer of Forest Read more...

Forest City Further Extends Nomination Window for 2018 Annual Meeting of Stockholders to ...

About Forest City Forest City Realty Trust, Inc. is an NYSE-listed national real estate company with $8.1 billionin consolidated assets. The Company is principally Read more...

PubMed Articles [541 Associated PubMed Articles listed on BioPortfolio]

Losing sight of the Forest for the trees: Why clinical laboratories need to perform their own interference studies.

Sustainability assessment in forest management based on individual preferences.

This paper presents a methodology to elicit the preferences of any individual in the assessment of sustainable forest management at the stand level. The elicitation procedure was based on the comparis...

Dominant forest tree mycorrhizal type mediates understory plant invasions.

Forest mycorrhizal type mediates nutrient dynamics, which in turn can influence forest community structure and processes. Using forest inventory data, we explored how dominant forest tree mycorrhizal ...

An eco-efficient and economical optimum evaluation technique for the forest road networks: the case of the mountainous forest of Metsovo, Greece.

The sustainable forest management can be achieved only through environmentally sound and economically efficient and feasible forest road networks and transportation systems that can potentially improv...

Repeatability and variability of total T4 measurements at three German veterinary laboratories.

To evaluate the reproducibility of serum testing for total thyroxine (T4) in three German laboratories.

Clinical Trials [282 Associated Clinical Trials listed on BioPortfolio]

Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers

The purpose of the study is to assess if the antimalarial drugs Dihydroartemisinine + Piperaquine (DP) are effective in preventing malaria infection for forest ranger

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [1031 Associated Companies listed on BioPortfolio]

Forest Laboratories, Inc. and Almirall, S.A.

Forest Laboratories' (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well-esta...

Forest Laboratories, Inc.

Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive...

Forest Laboratories

Forest Laboratories develops, manufactures and sells both branded and generic forms of ethical products which require a physician's prescription, as well as non-prescription pharmaceutical products so...

Almirall Ltd

Almirall, an international pharmaceutical company is based on innovation and committed to health. Headquartered in Barcelona, Spain, the company researches, develops, manufactures and commercialis...

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

More Information about "Forest Laboratories, Inc. and Almirall, S.A." on BioPortfolio

We have published hundreds of Forest Laboratories, Inc. and Almirall, S.A. news stories on BioPortfolio along with dozens of Forest Laboratories, Inc. and Almirall, S.A. Clinical Trials and PubMed Articles about Forest Laboratories, Inc. and Almirall, S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Forest Laboratories, Inc. and Almirall, S.A. Companies in our database. You can also find out about relevant Forest Laboratories, Inc. and Almirall, S.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record